Yang-Chang Wu
• Chair Professor, Graduate Institute of Natural Products, Kaohsiung Medical University (KMU), Taiwan
• Director, Research Center for Natural Products and Drug Development, KMU, Taiwan
• Researcher, Department of Medical Research, Kaohsiung Medical University Hospital, Taiwan
• Member, National Standards Technology Committee, Bureau of Standards, Metrology and Inspection,
Ministry of Economic Affairs, Taiwan
• Executive director (常務理事), Academia-Industry Consortium for Agricultural Biotechnology Park, Taiwan
• Director (理事), Academia-Industry Consortium for Southern Taiwan Science Park, Taiwan
• Executive director (常務理事), Niu-Chang-Chih (牛樟芝) Industry Association, Taiwan
• Chairman, National Standards Technical Committee, Niu-Chang-Chih Industry Association, Taiwan
• Consultant, Taiwan Institute of Economic Research
Education:
• Postdoctoral Fellow, Prof. Kuo-Hsiung Lee, University of North Carolina, U.S.A.
• Postdoctoral Fellow, Prof. Yoshimasa Hirata, Meijo University, Japan
• Doctor of Philosophy, Graduate Institute of Medicine (Basic Medical Science), KMU, Taiwan
• Master of Science, Graduate Institute of Medicine (Basic Medical Science), KMU, Taiwan
• Bachelor of Science in Pharmacy, KMU, Taiwan
Professional Experiences:
• 2010/08-2017/01 Vice-President, China Medical University (CMU), Taiwan
• 2014/08-2017/01 Chair Professor, School of Pharmacy, College of Pharmacy, CMU, Taiwan
• 2014/01-2016/12 Chairman, Division of Pharmacy and Chinese medicine, Department of Life Science,
Ministry of Science and Technology, Taiwan
• 2013/01-2015/12 Member, Experts on East Asian Herbal Medicine of the United States Pharmacopoeia
Committee, USA
• 2013/01-2015/12 Member, National Innovation Award Committee, Taiwan
• 2012/02-2014/07 Chair Professor & Dean, School of Pharmacy, College of Pharmacy, CMU, Taiwan
• 2011/02-2012/01 Chair Professor, School of Chinese Medicine, College of Chinese Medicine, CMU, Taiwan
• 2010/08-2011/01 Chair Professor, Graduate Institute of Integrated Medicine, College of Chinese Medicine,
CMU, Taiwan
• 2010/08-2014/07 Chair Professor(Joint Appointment), Graduate Institute of Natural Products, College of
Pharmacy, KMU, Taiwan
• 2009/08-2010/07 Chair Professor, Graduate Institute of Natural Products, College of Pharmacy, KMU, Taiwan
• 2008/01-2009/12 Member, National Standards Technology Committee, Bureau of Standards, Metrology and
Inspection, Ministry of Economic Affairs, Taiwan
• 2006/08-2009/07 Provost, Department of Research and Development, KMU, Taiwan
• 2002/01-2004/12 Chairman, Division of Pharmacy and Traditional Chinese Medicine, Department of
Biological and Medicine, National Science Council, Taiwan
• 1996/11-2010/10 Member, Committee on Chinese Medicine and Pharmacy, Department of Health, Executive
Yuan, Taiwan
• 1992/08-2006/07 Professor & Director, Graduate Institute of Natural Products, College of Pharmacy, KMU,
Taiwan
• 1990/08-1992/07 Professor, College of Pharmacy, KMU, Taiwan
• 1986/08-1990/07 Associate Professor, College of Pharmacy, KMU, Taiwan
Specialties:
Translational Research on Chinese Herbal Medicine and Natural Medicinal Products - Functional Food and New Drug Development
Awards and Honors:
¨ Member of the American Society of Pharmacognosy (ASP) and 10 more other association members. The member of 6 editorial board and ca. 30 referee member of journals
¨ 2017 Outstanding Venturing Award- Innovation and Startups Program
¨ 2015 12th National Innovation Award
¨ 2012 9th National Innovation Award-PhD Student (first prize)
¨ 2010 Outstanding Medical and Pharmaceutical Technology award of TienTe Lee Biomedical
Foundation, Taiwan
¨ 2009 Outstanding research award of National Science Council, Taiwan
¨ 2007 Outstanding merit and high scholastic achievement to medical and pharmaceutical
research award of Wang Ming-Ning Foundation
patent:
Title |
CYTOTOXIC ANNONACEOUS ACETOGENINS FROM ANNONA MURICATA |
||
Inventors |
Yang-Chang Wu |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I247009 |
Jan. 11, 2006 |
USA |
Utility Patent |
US 7,223,792 B2 |
May 29, 2007 |
Patent family 2 (5 patents)
Title |
COMPOSITION FOR TREATING CANCER CELLS AND PREPARATION METHOD THEREOF |
||
Inventors |
Yang-Chang Wu, An-Shen Lin, Fang-Rong Chang, Chin-Chung Wu |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I321052 |
Jan. 03, 2010 |
USA |
Utility Patent |
US 7,550,160 |
Jun. 23, 2009 |
USA |
Utility Patent |
US 7,670,630 |
Mar. 02, 2010 |
USA |
Utility Patent |
US 7,785,639 |
Aug. 31, 2010 |
USA |
Utility Patent |
US 7,887,856 |
Feb. 15, 2011 |
Patent family 3 (6 patents)
Title |
COMPOSITION FOR TREATING CANCER CELLS AND SYNTHESIS METHOD THEREOF |
||
Inventors |
Yang-Chang Wu, An-Shen Lin, Kuo-Hsiung Lee, Fang-Rong Chang |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I324062 |
May 01, 2010 |
USA |
Utility Patent |
US 7,842,721 |
Nov 30, 2010 |
Japan |
Utility Patent |
JP 5021549 |
Sep 12, 2012 |
Country |
Patent type |
Application number |
Date of filing |
Korean |
Utility Patent |
KR10-2008-0031721 |
Apr. 04, 2008 |
Australia |
Utility Patent |
AU 2008201553 |
Apr. 04, 2008 |
European union |
Utility Patent |
EP 08006865.3 |
Apr. 04, 2008 |
Patent family 4 (2 patents)
Title |
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND THE SIGNALING PATHWAY THEREOF |
||
Inventors |
Shyng-Shiou Yuan, Yang-Chang Wu, Hsueh-Ling Chang, Fang-Rong Chang |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I394568 |
May 01, 2013 |
Country |
Patent type |
Application number |
Date of filing |
USA |
Utility Patent |
US 12/399,155 |
Mar. 06, 2009 |
Patent family 5 (6 patents)
Title |
COMPOUND FOR INHIBITING GLUTATHIONE S-TRANSFERASE OMEGA 1 ACTIVITY, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, AND METHOD FOR SYNTHESIZING THE SAME |
||
Inventors |
Yang-Chang Wu, Kuo-Hsiung Lee, Fang-Rong Chang, Da-Wei Chuang, Juan-Cheng Yang |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I503315 |
Aug. 16, 2014 |
USA |
Utility Patent |
8,969,406 |
Aug. 07, 2014 |
China |
Utility Patent |
1944383 |
Aug. 13, 2014 |
Japan |
Utility Patent |
5778301 |
Aug. 25, 2014 |
Country |
Patent type |
Application number |
Date of filing |
European union |
Utility Patent |
13899167.4 |
Jun. 08, 2014 |
PCT |
Utility Patent |
PCT/CN2013/088871 |
Dec. 09, 2013 |
Patent family 6 (2 patents)
Title |
COMPOSITION FOR TREATING CANCER CELLS AND PREPARATION METHOD THEREOF |
||
Inventors |
Yang-Chang Wu, Fang-Rong Chang |
||
Country |
Patent type |
Patent number |
Date of Patent |
|
|
|
|
Country |
Patent type |
Application number |
Date of filing |
Taiwan |
Utility Patent |
TW 200916465 |
Apr. 16, 2009 |
USA |
Utility Patent |
US 2009/0088412 |
Apr. 02, 2009 |
Patent family 7 (2 patents)
Title |
COMPOSITION FOR TREATING INFLUENZA A (H1N1) VIRUS AND A PREPARATION METHOD THEREOF |
||
Inventors |
Yang-Chang Wu, Fang-Rong Chang, Lien-Chai Chiang |
||
Country |
Patent type |
Patent number |
Date of Patent |
USA |
Utility Patent |
US 8,476,311 |
Jul. 02, 2013 |
Country |
Patent type |
Application number |
Date of filing |
Taiwan |
Utility Patent |
TW 099104501 |
Feb. 11, 2010 |
Patent family 8 (2 patents)
Title |
ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF |
||
Inventors |
Yang-Chang Wu, Mei-Chin Lu, Fang-Rong Chang, Ying-Chi Du, Tung-Ying Wu |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I389699 |
Mar. 21, 2013 |
US |
Utility Paten |
8883167 |
Nov. 11, 2014 |
Patent family 9 (2 patents)
Title |
WATER EXTRACT OF ANTRODIA CAMPHORATA FOR IMMUNOSTIMULATORY EFFECT AND PREPARATION METHOD THEREOF |
||
Inventors |
Yang-Chang Wu, Mei-Chin Lu, Fang-Rong Chang, Ying-Chi Du, Tung-Ying Wu |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I448294 |
Aug 11, 2014 |
Country |
Patent type |
Application number |
Date of filing |
USA |
Utility Patent |
US 12/552,115 |
Sep 01, 2009 |
Patent family 10 (3 patents)
Title |
BENZENOID COMPOUNDS OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF |
||
Inventors |
Yang-Chang Wu, Mei-Chin Lu, Fang-Rong Chang, Ying-Chi Du, Tung-Ying Wu, Yu-Ming Hsu |
||
Country |
Patent type |
Patent number |
Date of Patent |
USA |
Utility Patent |
US 8,716,499 |
May 06, 2014 |
Country |
Patent type |
Application number |
Date of filing |
Taiwan |
Utility Patent |
TW 100100874 |
Jul 16, 2012 |
China |
Utility Patent |
CN201110078772 |
Jul 18, 2012 |
Patent family 11 (3 patents)
Title |
TRITERPENOID COMPOSITION OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF. Assignee: KAOHSIUNG MEDICAL UNIVERSITY |
||
Inventors |
Yang-Chang Wu, Mei-Chin Lu, Fang-Rong Chang, Ying-Chi Du, Tung-Ying Wu, Yu-Ming Hsu |
||
Country |
Patent type |
Patent number |
Date of Patent |
|
|
|
|
Country |
Patent type |
Application number |
Date of filing |
Taiwan |
Utility Patent |
TW 1001029 |
Oct 09, 2010 |
China |
Utility Patent |
CN201110092150 |
Aug 01, 2011 |
USA |
Utility Patent |
US 13/351,755 |
Jan 17, 2012 |
Patent family 12 (1 patents)
Title |
DROPPING PILL OF ANTRODIA CINNAMOMEA |
||
Inventors |
Tong-Rong Tsai、Yang-Chang Wu、Fang-Rong Chang、Mei-Chin Lu、Ying-Chi Du、Tung-Ying Wu、Yu-Ming Hsu、Kuei-Hung Lai、You-Cheng Lin、Yen-Chi Chen |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
M468314 |
Dec 21, 2013 |
Patent family 13 (1 patents)
Title |
DRINK CONTAINER OF ANTRODIA CINNAMOMEA FOR REDUCING ALCOHOL LEVEL AFTER ALCOHOL CONSUMPTION AND AWAKENING CONSCIOUSNESS |
||
Inventors |
Tong-Rong Tsai、Yang-Chang Wu、Fang-Rong Chang、Mei-Chin Lu、Ying-Chi Du、Tung-Ying Wu、Yu-Ming Hsu、Kuei-Hung Lai、You-Cheng Lin、Yen-Chi Chen、Ching-Peng Chiu、Shu-Fen Tu |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
M467624 |
Dec 11, 2013 |
Patent family 14(2 patent)
Title |
COMPOSITION FOR TREATING DIABETES AND METABOLIC DISEASES AND A PREPARATION METHOD THEREOF |
||
Inventors |
Yang-Chang Wu、Fang-Rong Chang、Tusty-Jiuan Hsieh、Ying-Chi Du、Yi-Hong Tsai、Chi-Ting Hsieh |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I417088 |
Dec 01, 2013 |
Country |
Patent type |
Application number |
Date of filing |
PCT |
Utility Patent |
PCT/US2012/49968 |
Aug 08, 2012 |
Patent family 15(1 patent)
Title |
COMPOSITION FOR TREATING ATHEROSCLEROSIS AND A PREPARATION METHOD THEREOF |
||
Inventors |
Yang-Chang Wu、Fang-Rong Chang、Tusty-Jiuan Hsieh、Suh-Hang Juo、An-Shen Lin、Ying-Chi Du |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I415600 |
Nov 21, 2013 |
Patent family 16 (3 patent)
Title |
EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF |
||
Inventors |
Pei-Jung Lien、Chuan-Chia Sun、Tzu-Chen Kuo、Sheng-Chung Yang、Yu-Ting Deng、Yang-Chang Wu、Fang-Rong Chang、Tusty-Jiuan Hsieh、I-Hung Tsai、Ying-Chi Du |
||
Country |
Patent type |
Patent number |
Date of filing |
Taiwan |
Utility Patent |
TW201121559 |
July 01, 2011 |
USA |
Utility Patent |
US20110159127 |
June 30, 2011 |
WIPO (PCT) |
Utility Patent |
WO/2011/082148 |
July 07, 2011 |
Patent family 17 (3patent)
Title |
CHEMICAL PROFILE OF DETECTING BIOACTIVE COMPONENTS OF QUINONES, STILBENES, FLAVONES AND ALKALOIDS |
||
Inventors |
Fang-Rong Chang、Tung-Ting Wu、Yang-Chang Wu |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I426266 |
Feb 11, 2014 |
Country |
Patent type |
Application number |
Date of filing |
USA |
Utility Patent |
US 13/528,131 |
Jan 03, 2013 |
China |
Utility Patent |
CN201110278881 |
Jan 02, 2013 |
Patent family 18 (1patent)
Title |
BENZENOID COMPOUNDS OF ANTRODIA CINNAMOMEA, PREPARATION AND ANALYSIS METHOD THEREOF |
||
Inventors |
Yang-Chang Wu、Fang-Rong Chang、Mei-Chin Lu、Ying-Chi Du、Tung-Ying Wu、Yu-Ming Hsu |
||
Country |
Patent type |
Patent number |
Date of Patent |
Taiwan |
Utility Patent |
I454301 |
Oct 01, 2014 |
China |
Utility Patent |
CN 102584777 B |
Jul 06, 2016
|
※ More than 574 research articles in SCI refereed journals and authorships of several book chapters. More than 40 patents granted or in application. More than 20 industry-academic cooperation. More than 6 patent/tech transfer practices (including one new drug R&D tech transfer).